Skip to Main Content

The Faculty of Medicine - Immunology and Cancer Research: Naor David


Last updated September 2023 -  Immunology and Cancer Research

List of Publications


Hemed-Shaked M, Cowman MK, Kim JR, Huang X, Chau E, Ovadia H, et al. MTADV 5-MER peptide suppresses chronic inflammations as well as autoimmune pathologies and unveils a new potential target-Serum Amyloid A. Journal of Autoimmunity [Internet]. 2021;124. Available from:


Murai T, Kawashima H, Naor D. Editorial: Cell-Cell and Cell-Matrix Adhesion in Immunobiology and Cancer. Frontiers in Immunology [Internet]. 2020;10. Available from:


Beider K, Naor D, Voevoda V, Ostrovsky O, Bitner H, Rosenberg E, et al. Dissecting the mechanisms involved in anti-human T-lymphocyte immunoglobulin (ATG)-induced tolerance in the setting of allogeneic stem cell transplantation - potential implications for graft versus host disease. Oncotarget [Internet]. 2017;8(53):90748–65. Available from:


Pinner E, Gruper Y, Ben Zimra M, Kristt D, Laudon M, Naor D, et al. CD44 Splice Variants as Potential Players in Alzheimer’s Disease Pathology. Journal of Alzheimer’s Disease [Internet]. 2017;58(4):1137–49. Available from:


Barzilay R, Ventorp F, Segal-Gavish H, Aharony I, Bieber A, Dar S, et al. CD44 Deficiency Is Associated with Increased Susceptibility to Stress-Induced Anxiety-like Behavior in Mice. Journal of Molecular Neuroscience [Internet]. 2016;60(4):548–58. Available from:


Naor D. Editorial: Interaction between hyaluronic acid and its receptors (CD44, RHAMM) regulates the activity of inflammation and cancer. Frontiers in Immunology [Internet]. 2016;7(FEB). Available from:


Assayag-Asherie N, Sever D, Bogdani M, Johnson P, Weiss T, Ginzberg A, et al. Can CD44 be a mediator of cell destruction? the challenge of type 1 diabetes. PLoS ONE [Internet]. 2015;10(12). Available from:


Gesundheit B, Ashwood P, Keating A, Naor D, Melamed M, Rosenzweig JP. Therapeutic properties of mesenchymal stem cells for autism spectrum disorders. Medical Hypotheses [Internet]. 2015;84(3):169–77. Available from:


Gesundheit B, Rosenzweig JP, Naor D, Lerer B, Zachor DA, Procházka V, et al. Immunological and autoimmune considerations of Autism Spectrum Disorders. Journal of Autoimmunity [Internet]. 2013;44:1–7. Available from:


Girbl T, Hinterseer E, Grössinger EM, Asslaber D, Oberascher K, Weiss L, et al. CD40-mediated activation of chronic lymphocytic leukemia cells promotes their CD44-dependent adhesion to hyaluronan and restricts CCL21-induced motility. Cancer Research [Internet]. 2013;73(2):561–70. Available from:


Shimony O, Nagler A, Gellman YN, Refaeli E, Rosenblum N, Eshkar-Sebban L, et al. Anti-T lymphocyte globulin (ATG) induces generation of regulatory T cells, at least part of them express activated CD44. Journal of Clinical Immunology [Internet]. 2012;32(1):173–88. Available from:


Turley EA, Naor D. RHAMM and CD44 peptides-analytic tools and potential drugs. Frontiers in Bioscience [Internet]. 2012;17(5):1775–94. Available from:


Kahaly GJ, Shimony O, Gellman YN, Lytton SD, Eshkar-Sebban L, Rosenblum N, et al. Regulatory T-cells in Graves’ orbitopathy: Baseline findings and immunomodulation by anti-T lymphocyte globulin. Journal of Clinical Endocrinology and Metabolism [Internet]. 2011;96(2):422–9. Available from:


Naor D, Wallach-Dayan SB, Zahalka MA, Sionov RV. Involvement of CD44, a Molecule with a Thousand Faces, in Cancer Dissemination [Internet]. Hyaluronan in Cancer Biology. 2009. Available from:


Vagima Y, Avigdor A, Goichberg P, Shivtiel S, Tesio M, Kalinkovich A, et al. MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilization. Journal of Clinical Investigation [Internet]. 2009;119(3):492–503. Available from:


Wallach-Dayan SB, Rubinstein AM, Hand C, Breuer R, Naor D. DNA vaccination with CD44 variant isoform reduces mammary tumor local growth and lung metastasis. Molecular Cancer Therapeutics [Internet]. 2008;7(6):1615–23. Available from:


Naor D, Wallach-Dayan SB, Zahalka MA, Sionov RV. Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. Seminars in Cancer Biology [Internet]. 2008;18(4):260–7. Available from:


Gonen E, Nedvetzki S, Naor D, Shpigel NY. CD44 is highly expressed on milk neutrophils in bovine mastitis and plays a role in their adhesion to matrix and mammary epithelium. Veterinary Research [Internet]. 2008;39(3). Available from:


Weiss L, Botero-Anug AM, Hand C, Slavin S, Naor D. CD44 gene vaccination for insulin-dependent diabetes mellitus in non-obese diabetic mice. Israel Medical Association Journal [Internet]. 2008;10(1):20–5. Available from:


Sebban LE, Ronen D, Levartovsky D, Elkayam O, Caspi D, Aamar S, et al. The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammation. Journal of Immunology [Internet]. 2007;179(2):1225–35. Available from:


Garin T, Rubinstein A, Grigoriadis N, Nedvetzki S, Abramsky O, Mizrachi-Koll R, et al. CD44 variant DNA vaccination with virtual lymph node ameliorates experimental autoimmune encephalomyelitis through the induction of apoptosis. Journal of the Neurological Sciences [Internet]. 2007;258(1–2):17–26. Available from:


Golan I, Nedvetzki S, Golan I, Eshkar-Sebban L, Levartovsky D, Elkayam O, et al. Expression of extra trinucleotide in CD44 variant of rheumatoid arthritis patients allows generation of disease-specific monoclonal antibody. Journal of Autoimmunity [Internet]. 2007;28(2–3):99–113. Available from:


Naor D, Nedvetzki S, Walmsley M, Yayon A, Turley EA, Golan I, et al. CD44 involvement in autoimmune inflammations: The lesson to be learned from CD44-targeting by antibody or from knockout mice. Annals of the New York Academy of Sciences [Internet]. 2007;1110:233–47. Available from:


Nedvetzki S, Gonen E, Assayag N, Reich R, Williams RO, Thurmond RL, et al. Erratum: RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: A different interpretation of redundancy (Proceedings of the National Academy of Sciences of the United States of America (December 28, 2004) 101, 52 (18081-18086)). Proceedings of the National Academy of Sciences of the United States of America [Internet]. 2005;102(4):1263. Available from:


Naor D, Nedvetzki S, Assayag N, Thurmond RL, Huang JF, Turley EA. The mechanism of molecular redundancy in autoimmune inflammation in the context of CD44 deficiency. Annals of the New York Academy of Sciences [Internet]. 2005;1050:52–63. Available from:


Nedvetzki S, Gonen E, Assayag N, Reich R, Williams RO, Thurmond RL, et al. RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: A different interpretation of redundancy. Proceedings of the National Academy of Sciences of the United States of America [Internet]. 2004;101(52):18081–6. Available from:


Avigdor A, Goichberg P, Shivtiel S, Dar A, Peled A, Samira S, et al. CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood [Internet]. 2004;103(8):2981–9. Available from:


Naor D, Nedvetzki S. CD4 in rheumatoid arthritis. Arthritis Research and Therapy [Internet]. 2003;5(3):105–15. Available from:


Ursø B, Ilondo MM, Holst PA, Christoffersen CT, Ouwens M, Giorgetti S, et al. IRS-4 mediated mitogenic signalling by insulin and growth hormone in LB cells, a murine T-cell lymphoma devoid of IGF-I receptors. Cellular Signalling [Internet]. 2003;15(4):385–94. Available from:


Nedvetzki S, Golan I, Assayag N, Gonen E, Caspi D, Gladnikoff M, et al. A mutation in a CD44 variant of inflammatory cells enhances the mitogenic interaction of FGF with its receptor. Journal of Clinical Investigation [Internet]. 2003;111(8):1211–20. Available from:


Guy R, Yefenof E, Naor D, Dorogin A, Zilberman Y. CD44 co-stimulates apoptosis in thymic lymphomas and T cell hybridomas. Cellular Immunology [Internet]. 2002;216(1–2):82–92. Available from:


Naor D, Nedvetzki S, Golan I, Melnik L, Faitelson Y. CD44 in cancer. Critical Reviews in Clinical Laboratory Sciences [Internet]. 2002;39(6):527–79. Available from:


Wallach-Dayan SB, Grabovsky V, Moll J, Sleeman J, Herrlich P, Alon R, et al. CD44-dependent lymphoma cell dissemination: A cell surface CD44 variant, rather than standard CD44, supports in vitro lymphoma cell rolling on hyaluronic acid substrate and its in vivo accumulation in the peripheral lymph nodes. Journal of Cell Science [Internet]. 2001;114(19):3463–77. Available from:


Batya Wallach S, Friedmann A, Naor D. The CD44 receptor of the mouse LB T-cell lymphoma: Analysis of the isoform repertoire and ligand binding properties by reverse-transcriptase polymerase chain reaction and antisense oligonucleotides. Cancer Detection and Prevention [Internet]. 2000;24(1):33–45. Available from:


Weiss L, Slavin S, Reich S, Cohen P, Shuster S, Stern R, et al. Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody. Proceedings of the National Academy of Sciences of the United States of America [Internet]. 2000;97(1):285–90. Available from:


Rochman M, Moll J, Herrlich P, Wallach SB, Nedvetzki S, Sionov RV, et al. The CD44 receptor of lymphoma cells: Structure-function relationships and mechanism of activation. Cell Adhesion and Communication [Internet]. 2000;7(4):331–47. Available from:


Nedvetzki S, Walmsley M, Alpert E, Williams RO, Feldmann M, Naor D. CD44 involvement in experimental collagen-induced arthritis (CIA). Journal of Autoimmunity [Internet]. 1999;13(1):39–47. Available from:


Sionov RV, Naor D. Calcium- and calmodulin-dependent PMA-activation of the CD44 adhesion molecule. Cell Adhesion and Communication [Internet]. 1998;6(6):503–23. Available from:


Naor D, Vogt Sionov R, Zahalka M, Rochman M, Holzmann B, Ish-Shalom D. Organ-specific requirements for cell adhesion molecules during lymphoma cell dissemination. Current Topics in Microbiology and Immunology [Internet]. 1997;231:143–66. Available from:


Ish-Shalom D, Christoffersen CT, Vorwerk P, Sacerdoti-Sierra N, Shymko RM, Naor D, et al. Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor. Diabetologia [Internet]. 1997;40(SUPPL. 2):S25–31. Available from:


Sionov RV, Naor D. Hyaluronan-independent lodgment of CD44+ lymphoma cells in lymphoid organs. International Journal of Cancer [Internet]. 1997;71(3):462–9. Available from:


Naor D, Sionov RV, Ish-Shalom D. CD44: Structure, function, and association with the malignant process. Advances in Cancer Research [Internet]. 1997;71:241–319. Available from:


Gosslar U, Jonas P, Luz A, Lifka A, Naor D, Hamann A, et al. Predominant role of α4-integrins for distinct steps of lymphoma metastasis. Proceedings of the National Academy of Sciences of the United States of America [Internet]. 1996;93(10):4821–6. Available from:


Rocha M, Krüger A, Umansky V, Von Hoegen P, Naor D, Schirrmacher V. Dynamic expression changes in vivo of adhesion and costimulatory molecules determine load and pattern of lymphoma liver metastasis. Clinical Cancer Research [Internet]. 1996;2(5):811–20. Available from:


Urs⊘ B, Christoffersen CT, Tornqvist H, De Meyts P, Ouwens M, Vlahos C, et al. Mitogenic signalling by insulin in a T-cell lymphoma, the LB cell line, devoid of IGF-I receptors: Evidence for the lack of involvement of the RAS-MAP kinase pathway and for a possibly novel IRS-like molecule. Experimental and Clinical Endocrinology and Diabetes [Internet]. 1996;104:52–3. Available from:


ISH‐SHALOM D, TZIVION G, CHRISTOFFERSEN CT, URSØ B, DE MEYTS P, NAOR D. Mitogenic Potential of Insulin on Lymphoma Cells Lacking IGF‐1 Receptor. Annals of the New York Academy of Sciences [Internet]. 1995;766(1):409–14. Available from:


Zahalka MA, Okon E, Gosslar U, Holzmann B, Naor D. Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent. Journal of Immunology [Internet]. 1995;154(10):5345–55. Available from:


Stock R, Naor D. Induction of an autoimmune response against syngeneic lymphoma cells by immunogenic 64-kDa protein isolated from normal blast cells of BALB/c mice. Cancer Immunology Immunotherapy [Internet]. 1995;40(1):48–56. Available from:


Zahalka MA, Naor D. β2-lntegrin dependent aggregate formation between LB T cell lymphoma and spleen cells: Assessment of correlation with spleen invasiveness. International Immunology [Internet]. 1994;6(6):917–24. Available from:


Sharon R, Pillemer G, Ish‐Shalom D, Kalman R, Ziv E, Berry EM, et al. Insulin dependence of murine T‐cell lymphoma. II. Insulin‐deficient diabetic mice and mice fed low‐energy diet develop resistance to lymphoma growth. International Journal of Cancer [Internet]. 1993;53(5):843–9. Available from:


Zahalka MA, Okon E, Naor D. Blocking lymphoma invasiveness with a monoclonal antibody directed against the β-chain of the leukocyte adhesion molecule (CD18). Journal of Immunology [Internet]. 1993;150(10):4466–77. Available from:


Naor D. Bifunctional T cell clones challenge the traditional compartmentalization concept of the immune system. Archivum Immunologiae et Therapiae Experimentalis [Internet]. 1992;40(1):67–70. Available from:


Sharon R, Naor D. Experimental model of autoimmune hemolytic anemia induced in mice with levodopa by intraperitoneal injection or oral feeding. International Journal of Immunopharmacology [Internet]. 1992;14(7):1241–7. Available from:


Pillemer G, Lugasi‐Evgi H, Scharovsky G, Naor D. Insulin dependence of murine lymphoid T‐cell leukemia. International Journal of Cancer [Internet]. 1992;50(1):80–5. Available from:


Naor D. A different outlook at the phenotype-function relationships of T cell subpopulations: Fundamental and clinical implications. Clinical Immunology and Immunopathology [Internet]. 1992;62(2):127–32. Available from:


NAOR D, ESSERY G, TARCIC N, KAHAN M, FELDMANN M. Regulatory Interactions among Autologous T Cell Clones Human Bifunctional T Cell Clones Regulate the Activity of an Autologous T Cell Clone. Annals of the New York Academy of Sciences [Internet]. 1991;636(1):135–46. Available from:


Zahalka MA, Naor D. Inflammatory response induced with an isolated syngeneic activation antigen shared by normal lymphoblasts and YAC lymphoma cells. Clinical Immunology and Immunopathology [Internet]. 1991;59(1):72–88. Available from:


Naor D, Essery G, Tarcic N, Kahan M, Feldmann M. Interactions between autologous T cell clones. Cellular Immunology [Internet]. 1990;128(2):490–502. Available from:


Naor D, Essery G, Taroc N, Kahan M, Lamb JR, Feldmann M. Specific Interactions between a Human CD4+ Clone and Autologous CD4+ Bifunctional Immunoregulatory Clones. Immunological Reviews [Internet]. 1990;116(1):63–83. Available from:


Lugasi H, Hajos S, Murphy JR, Strom TB, Nichols J, Peñarroja C, et al. Murine spontaneous T‐cell leukemia constitutively expressing IL‐2 receptor—a model for human T‐cell malignancies expressing IL‐2 receptor. International Journal of Cancer [Internet]. 1990;45(1):163–7. Available from:


Duke-Cohan JS, Rubinow A, Hirt R, Naor D. The reaction against autologous lymphoblasts as an indicator of lymphocyte hyperreactivity in rheumatoid arthritis. Clinical Immunology and Immunopathology [Internet]. 1990;54(2):298–308. Available from:


Alvarez E, Mongini C, Waldner CI, Fenandez TB, Naor D, Hajos SE. The inter-relationships between spontaneous murine T cell leukaemia LB and the immune system: LB is a nonimmunogenic tumor in its syngeneic host. Journal of Experimental and Clinical Cancer Research [Internet]. 1989;8(4):181–92. Available from:


Naor D, Essery G, Tarcic N, De Berardinis P, Kahan M, Feldmann M. Autoreactivity against class I or class II antigens - Immunological downregulation mechanism? Bulletin de l’Institut Pasteur [Internet]. 1989;87(1):3–17. Available from:


DUKE‐COHAN JS, HIRT R, ROTTEM M, BEN‐ZVI A, RUBINOW A, NAOR D. Use of an autologous reaction in vitro to assess contributions of T and B lymphocytes to immune hyperreactivity of atopics. Clinical & Experimental Allergy [Internet]. 1989;19(2):163–8. Available from:


Sharon R, Naor D. Experimental model of autoimmune hemolytic anemia induced in mice with Levodopa. Clinical Immunology and Immunopathology [Internet]. 1989;52(2):160–72. Available from:


Tarcic N, David CS, Naor D. Auto-delayed-type hypersensitivity induced in immunodeficient mice with modified self-antigens. V. Cellular autoreactivity directed against self-H-2D(d) subregion mediates the inflammatory responses. Immunology [Internet]. 1989;67(2):184–90. Available from:


Sharon R, Giloh H, Naor D. Experimental autoimmune anemia induced with haptenated syngeneic mouse red blood cells and low dose X-irradiation. Clinical Immunology and Immunopathology [Internet]. 1988;47(3):310–22. Available from:


KLEIN I, NAOR D. Self‐Reactive Delayed Type Hypersensitivity Induced in Mice by Syngeneic Lymphoblasts: III. Immunological Characterization of the Small and Large Antigens of the Blast Cells. Scandinavian Journal of Immunology [Internet]. 1988;27(4):385–92. Available from:


Klein I, Naor D. Autoinflammatory response to self-antigens of lymphoblasts. Israel Journal of Medical Sciences [Internet]. 1988;24(7):373–4. Available from:


KLEIN I, KLEIN BY, NAOR D. Self‐Reactive Delayed Type Hypersensitivity Induced in Mice by Syngeneic Lymphoblasts: II. Isolation of Two Distinct Lymphoblast Antigens, One of Which Reacts (or Cross‐Reacts) with Anti‐H‐2Dd Monoclonal Antibody. Scandinavian Journal of Immunology [Internet]. 1988;27(2):209–22. Available from:


Naor D. Suppressor cells and human malignancy. Clinical Immunology Newsletter [Internet]. 1987;8(5):65–9. Available from:


Duke-Cohan JS, Hirt R, Dahan A, Naor D. On the immune reaction to autologous human lymphoblasts: Evidence for the stimulation by activating factors rather than induction by autoantigens. Clinical Immunology and Immunopathology [Internet]. 1987;43(2):229–42. Available from:


Naor D, Duke-Cohan JS. Suppressor cells and malignancy. I. Suppressor macrophages and suppressor T cells in experimental animals. Advances in immunity and cancer therapy [Internet]. 1986;2:1–129. Available from:


Kelley VE, Naor D, Tarcic N, Gaulton GN, Strom TB. Anti-interleukin 2 receptor antibody suppresses delayed-type hypersensitivity to foreign and syngeneic antigens. Journal of Immunology [Internet]. 1986;137(7):2122–4. Available from:


Tarcic N, Naor D. The genetic control of syngeneic delayed type hypersensitivity (syn-DTH). Immunogenetics [Internet]. 1986;24(2):131–4. Available from:


Hutchings P, Naor D, Cooke A. Effects of low doses of cyclophosphamide and low doses of irradiation on the regulation of induced erythrocyte autoantibodies in mice. Immunology [Internet]. 1985;54(1):97–104. Available from:


Naor D, Tarcic N, Baler R. Control of in vivo immunological autoreactivities with suppressive T cell factor derived from a hybridoma cell line. Transplantation Proceedings [Internet]. 1985;17(6):2617–21. Available from:


Langer A, Rosenmann E, Naor D. The effect of cyclosporin on murine autoreactive delayed type hypersensitivity induced with syngeneic lymphoblasts. Immunopharmacology [Internet]. 1985;10(3):147–55. Available from:


Naor D, Langer A. Analysis of the cyclosporine mechanism in an immunological autoreactive model of delayed-type hypersensitivity. Transplantation Proceedings [Internet]. 1985;17(6):2706–8. Available from:


Duke-Cohan JS, Weinberg H, Sharon R, Naor D. Immunological function in osteoporosis. Clinical Immunology and Immunopathology [Internet]. 1985;35(1):125–9. Available from:


Klein I, Naor D. Self Reactive Delayed Type Hypersensitivity (DTH) Induced in Mice by Syngeneic Lymphoblasts. Immunobiology [Internet]. 1985;169(1):45–59. Available from:


Klein BY, Frenkel S, Naor D. Isolated soluble fractions from the murine B16 melanoma induce primary in vitro syngeneic antitumor responses. Cancer Immunology Immunotherapy [Internet]. 1984;18(3):195–202. Available from:


Sharon R, Naor D. The isolation of immunogenic molecular entities from immunogenic and nonimmunogenic tumor homogenates by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Cancer Immunology Immunotherapy [Internet]. 1984;18(3):203–8. Available from:


TARCIC N, BALER R, NAOR D. Auto‐Delayed‐Type Hypersensitivity Induced in Immunodeficient Mice withModified Self‐Antigens: III. Suppressive T‐Cell Factor Controls the Autoreactivity against Self‐Antigens. Scandinavian Journal of Immunology [Internet]. 1984;20(5):389–401. Available from:


TARCIC N, KLEIN BY, NAOR D. Auto‐Delayed‐Type Hypersensitivity Induced in Immunodeficient Mice with Modified Self‐Antigens: IV. Characterization of the Suppressive T‐Cell Factor that Controls the Autoreactivity against Self‐Antigens. Scandinavian Journal of Immunology [Internet]. 1984;20(5):403–11. Available from:


Adler A, Stein JA, Kedar E, Naor D, Weiss DW. Intralesional injection of interleukin-2 — Expanded autologous lymphocytes in melanoma and breast cancer patients: A pilot study. Journal of Biological Response Modifiers [Internet]. 1984;3(5):491–500. Available from:


TARCIC N, SHARON R, ROSENMANN E, NAOR D. Auto‐Delayed‐Type Hypersensitivity Induced in Immunodeficient Mice with Syngeneic Modified Self‐Antigens: II. Suppressor T Cells Control the Autoimmune Response. Scandinavian Journal of Immunology [Internet]. 1984;19(2):111–21. Available from:


Klein BY, Frenkel S, Naor D. Isolation of murine melanoma antigens crossreactive with human melanoma antigens, detected by cell mediated cytotoxicity. Federation Proceedings [Internet]. 1984;43(6):no. 1194. Available from:


Naor D. Coexistence of immunogenic and suppressogenic epitopes in tumor cells and various types of macromolecules. Cancer Immunology Immunotherapy [Internet]. 1983;16(1):1–10. Available from:


Ahituv A, Naor D, Sharon R, Tarcic N, Klein BY. Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors - III. Stimulation of syngeneic antitumor responses by subcellular fractions and molecular species of moloney virus-induced tumors in CBA and a mice. Cancer Immunology Immunotherapy [Internet]. 1982;14(1):16–26. Available from:


Klein BY, Sharon R, Tarcic N, Naor D. Induction of Antitumor Reactive Cells or Suppressor Cells by Different Molecular Species Isolated from the Same Nonimmunogenic Tumor. Immunobiology [Internet]. 1982;163(1):7–21. Available from:


Tarcic N, Naor D. Delayed‐type hypersensitivity induced in immunodeficient mice with syngeneic modified self antigens: a suggestive model of autoimmune response. European Journal of Immunology [Internet]. 1982;12(11):961–6. Available from:


Naor D, Tarcic N. CONTROL OF AUTOIMMUNE RESPONSES INDUCED WITH MODIFIED SELF ANTIGENS. Annals of the New York Academy of Sciences [Internet]. 1982;392(1):178–90. Available from:


Klein BY, Devens B, Deutsch O, Ahituv A, Frenkel S, Kobrin BJ, et al. Isolation of immunogenic and suppressogenic determinants of the nonimmunogenic YAC tumor and the change in its immunogenic repertoire after in vitro cultivation. Transplantation Proceedings [Internet]. 1981;13(1):790–7. Available from:


Kobrin BJ, Naor D, Klein BY. Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors. II. Stimulation of syngeneic anti-tumor cell-mediated immune responses by subcellular fractions and molecular species of the Rauscher-virus-induced RBL5 tumor. Journal of Immunology [Internet]. 1981;126(5):1874–82. Available from:


Devens B, Deutsch O, Avraham Y, Naor D. Immune Response to Weakly Immunogenic Virally Induced Tumors. IX. Mice Injected with the in vitro Variant of YAC Tumor (YAC-1) Resist Lethal Doses of the Tumorgenic YAC Cells. Immunobiology [Internet]. 1981;159(4–5):432–43. Available from:


Naor D. Unresponsiveness to Modified Self Antigens ‐ A Censorship Mechanism Controlling Autoimmunity? Immunological Reviews [Internet]. 1980;50(1):187–226. Available from:


Klein BY, Frenkel S, Ahituv A, Naor D. Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors. I. screening of immunogenic components by isopycnic ultracentrifugation and polyacrylamide electrophoresis of a tumor homogenate. Journal of Immunological Methods [Internet]. 1980;38(3–4):325–41. Available from:


Leshem B, Naor D. Studies on the immune response to fixed antigens. IV. Recall of immunologic memory with fixed antigens. Israel Journal of Medical Sciences [Internet]. 1980;16(1):25–32. Available from:


Deutsch O, Devens B, Naor D. Immune responses to weakly immunogenic murine-leukemia-virus-induced tumors. VII. Kinetic studies on various parameters of effects induced with suppressor cells. Israel Journal of Medical Sciences [Internet]. 1980;16(7):530–7. Available from:


Deutsch O, Devens B, Naor D. Immune responses to weakly immunogenic murine-leukemia-virus-induced tumors. VIII. Characterization of suppressor cells. Israel Journal of Medical Sciences [Internet]. 1980;16(7):538–44. Available from:


Devens B, Naor D. Immune responses to weakly immunogenic virally induced tumors. VI. Comparison of the immune response of the hybrid to the immune responses of the parents reveals “hybrid responsiveness” effect. Journal of Immunology [Internet]. 1980;125(3):988–94. Available from:


Devens B, Naor D, Kedar E. Immune response to weakly immunogenic virally induced tumors iv dissociated recognition of H-2 and tumor associated antigens: IV dissociated recognition of h 2 and tumor associated antig4ens. Transplantation [Internet]. 1979;28(5):389–95. Available from:


Devens B, Schochot L, Naor D. Immune responses to weakly immunogenic virally induced tumors. V. Short in vitro cultivation of YAC changes its antigenic properties. Cellular Immunology [Internet]. 1979;44(2):442–53. Available from:


Naor D. Suppressor cells: Permitters and promoters of malignancy? Advances in Cancer Research [Internet]. 1979;29(C):45–125. Available from:


Devens B, Naor D. Immune responses to weakly immunogenic virally induced tumors. III. Genetically unrestricted cytolysis of allogeneic tumor target cells. Journal of Immunology [Internet]. 1979;122(4):1397–401. Available from:


Ashman RF, Naor D. Membrane defects of the tolerant B cell. I. Failure of antigen-induced capping. Cellular Immunology [Internet]. 1979;44(2):314–28. Available from:


Leshem B, Naor D. Studies on the immune response to fixed antigens. III. Induction of helper function for antibody-dependent cellular cytotoxicity responses. Journal of Immunology [Internet]. 1978;121(2):401–8. Available from:


Devens B, Galili N, Deutsch O, Naor D, Klein E. Immune responses to weakly immunogenic virally induced tumors II. Suppressive effects of the in vivo carried tumor YAC. European Journal of Immunology [Internet]. 1978;8(8):573–8. Available from:


Leshem B, Naor D. Cellular assay for measuring anti-erythrocyte antibody responses. Journal of Immunological Methods [Internet]. 1978;20(C):263–75. Available from:


Galili N, Devens B, Naor D, Becker S, Klein E. Immune responses to weakly immunogenic virally induced tumors I. Overcoming low responsiveness by priming mice with a syngeneic in vitro tumor line or allogeneic cross‐reactive tumor. European Journal of Immunology [Internet]. 1978;8(1):17–22. Available from:


Naor D, O’Toole C. Cryopreservation of immunological memory and other lymphoid cell functions. Journal of Immunological Methods [Internet]. 1977;16(4):361–70. Available from:


Naor D, Kahan M. Studies on the immune response to fixed antigens. II. Optimal conditions for inducing and eliciting helper function by fixed antigens and the mechanism responsible for this effect. Israel Journal of Medical Sciences [Internet]. 1977;13(6):561–76. Available from:


Naor D, Galili N. Immune response to chemically modified antigens. Progress in Allergy [Internet]. 1977;Vol. 22:107–46. Available from:


Kedar E, Unger E, Galili N, Klein G, Asjo B, Bonavida B, et al. Immunogenicity of tumor cells modified by trinitrobenzene suflonic acid (TNBS). Progress in clinical and biological research [Internet]. 1976;9:109–21. Available from:


Kahan M, Berman Goldman R, Salton R, Naor D. Studies on the immune response to fixed antigens. Preferential induction of helper function with heavily trinitrophenylated sheep erythrocytes, and glutaraldehyde treated sheep erythrocytes. Journal of Immunology [Internet]. 1976;117(1):16–22. Available from:


Naor D, Bonavida B, Walford RL. Autoimmunity and aging: the age related response of mice of a long lived strain to trinitrophenylated syngeneic mouse red blood cells. Journal of Immunology [Internet]. 1976;117(6):2204–8. Available from:


Galili N, Naor D, Åsjö B, Klein G. Induction of immune responsiveness in a genetically low‐responsive tumor‐host combination by chemical modification of the immunogen. European Journal of Immunology [Internet]. 1976;6(7):473–6. Available from:


Naor D, Bonavida B, Robinson RA, Shibata IN, Percy DE, Chia D, et al. Immune response of New Zealand mice to trinitrophenylated syngeneic mouse red cells. European Journal of Immunology [Internet]. 1976;6(11):783–9. Available from:


Naor D, Berman-Goldman R, Kahan M, Goldfisher H, Laskov R, Simon E, et al. Induction of hapten recognizing helper function by heavily trinitrophenylated sheep erythrocytes. Advances in experimental medicine and biology [Internet]. 1976;66:253–60. Available from:


Naor D, Falkenberg F, Saltoun R. Proceedings: Mouse immune response to trinitrophenylated red cells. Israel Journal of Medical Sciences [Internet]. 1975;11(12):1377–8. Available from:


Naor D, Saltoun R, Falkenberg F. Lack of requirement for thymocytes for efficient antibody formation to trinitrophenylated mouse red cells in mice: Role for thymocytes in suppression of the immune response. European Journal of Immunology [Internet]. 1975;5(3):220–3. Available from:


Zolla S, Naor D, Tanapatchaiyapong P. Cellular basis of immunodepression in mice with plasmacytomas. Journal of Immunology [Internet]. 1974;112(6):2068–76. Available from:


Zolla S, Naor D. Restoration of immune competence in tolerant mice by parabiosis to normal mice. Journal of Experimental Medicine [Internet]. 1974;140(5):1421–6. Available from:


Sulitzeanu D, Morecki S, Naor D. Specific interactions of antigen with cells studied by means of rosette formation. Israel Journal of Medical Sciences [Internet]. 1974;10(11):1397–404. Available from:


Naor D, Morecki S, Mitchell GF. Differential induction of anti‐trinitrophenyl plaque‐forming cell responses to lightly and heavily conjugated trinitrophenylated heterologous and autologous erythrocytes in mice. European Journal of Immunology [Internet]. 1974;4(4):311–4. Available from:


Naor D, Morecki S, Kedar E. Differential induction and suppression of direct and indirect PFC responses to TNP conjugated to heterologous erythrocytes. Advances in experimental medicine and biology [Internet]. 1973;29:225–32. Available from:


Naor D, Mishell R. In vitro immunity to TNP and penicillin: specific inhibition with hapten-conjugated isologous red cells. Journal of Immunology [Internet]. 1972;108(1):246–52. Available from:


Naor D, Henry C, Fudenberg HH. An in vitro immune response to penicillin. Journal of Immunology [Internet]. 1971;107(1):302–5. Available from:


Wofsy L, Truffa‐Bachi P, Naor D. CHEMICAL APPROACHES TO THE CELL RECEPTOR PROBLEM. Annals of the New York Academy of Sciences [Internet]. 1971;190(1):432–42. Available from:


Naor D, Mishell RI, Wofsy L. Specific inhibition of an anti-hapten immune response by chemical modifications of cells. Journal of Immunology [Internet]. 1970;105(6):1322–6. Available from:


Naor D, Sulitzeanu D. Affinity of radioiodinated bovine serum albumin for lymphoid cells. 3. Further experiments with cells of normal animals. Israel Journal of Medical Sciences [Internet]. 1970;6(4):519–22. Available from:


Naor D. The structure of immunoglobulins. Harefuah [Internet]. 1969;77(11):528. Available from:


Naor D, Sulitzeanu D. Affinity of radioiodinated bovine serum albumin for lymphoid cells. Binding of I-125-BSA to lymphoid cells of immune mice. Israel Journal of Medical Sciences [Internet]. 1969;5(2):217–29. Available from:


Naor D, Bentwich Z, Cividalli G. Inability of peripheral lymphoid cells of agammaglobulinaemic patients to bind radioiodinated albumins. The Australian journal of experimental biology and medical science [Internet]. 1969;47(6):759–61. Available from:


Naor D, Sulitzeanu D. Binding of 125I-BSA to lymphoid cells of tolerant mice. International Archives of Allergy and Applied Immunology [Internet]. 1969;36(1):112–3. Available from:


Sulitzeanu D, Naor D. The affinity of radioiodinated BSA for lymphoid cells. II. Binding of 125I-BSA to lymphoid cells of normal mice. International Archives of Allergy and Applied Immunology [Internet]. 1969;35(6):564–78. Available from:


Naor D, Sulitzeanu D. Binding of radioiodinated bovine serum albumin to lymphoid cells of specifically primed or immunized mice in vitro. Life Sciences [Internet]. 1968;7(8 PART 2):377–82. Available from:


Naor D, Sulitzneau D. Binding of radioiodinated bovine serum albumin to mouse spleen cells. Nature [Internet]. 1967;214(5089):687–8. Available from: